Geode Capital Management LLC raised its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 6.0% during the first quarter, Holdings Channel reports. The firm owned 91,309 shares of the company’s stock after buying an additional 5,130 shares during the period. Geode Capital Management LLC’s holdings in U.S. Physical Therapy were worth $5,962,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Vanguard Group Inc. raised its position in shares of U.S. Physical Therapy by 6.5% in the first quarter. Vanguard Group Inc. now owns 641,533 shares of the company’s stock valued at $41,892,000 after buying an additional 39,290 shares during the period. Aberdeen Asset Management PLC UK raised its position in shares of U.S. Physical Therapy by 11.0% in the first quarter. Aberdeen Asset Management PLC UK now owns 621,754 shares of the company’s stock valued at $40,601,000 after buying an additional 61,715 shares during the period. Principal Financial Group Inc. raised its position in shares of U.S. Physical Therapy by 3.8% in the first quarter. Principal Financial Group Inc. now owns 100,739 shares of the company’s stock valued at $6,578,000 after buying an additional 3,670 shares during the period. Legato Capital Management LLC raised its position in shares of U.S. Physical Therapy by 6,430.0% in the first quarter. Legato Capital Management LLC now owns 95,534 shares of the company’s stock valued at $1,463,000 after buying an additional 94,071 shares during the period. Finally, Scout Investments Inc. raised its position in shares of U.S. Physical Therapy by 20.6% in the first quarter. Scout Investments Inc. now owns 89,470 shares of the company’s stock valued at $4,449,000 after buying an additional 15,275 shares during the period. Institutional investors and hedge funds own 96.10% of the company’s stock.

U.S. Physical Therapy, Inc. (NYSE USPH) opened at 62.35 on Thursday. The firm’s 50 day moving average price is $62.60 and its 200 day moving average price is $66.14. The stock has a market cap of $784.43 million, a price-to-earnings ratio of 39.46 and a beta of 1.06. U.S. Physical Therapy, Inc. has a 12 month low of $51.96 and a 12 month high of $78.00.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.60 by $0.01. U.S. Physical Therapy had a net margin of 5.65% and a return on equity of 12.91%. The firm had revenue of $104.25 million during the quarter, compared to analysts’ expectations of $102.93 million. On average, equities research analysts predict that U.S. Physical Therapy, Inc. will post $2.13 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 8th. Investors of record on Monday, August 21st will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Thursday, August 17th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.27%. U.S. Physical Therapy’s payout ratio is currently 46.78%.

COPYRIGHT VIOLATION WARNING: “U.S. Physical Therapy, Inc. (NYSE:USPH) Position Increased by Geode Capital Management LLC” was first published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US and international copyright and trademark laws. The original version of this piece of content can be read at https://www.watchlistnews.com/u-s-physical-therapy-inc-nyseusph-position-increased-by-geode-capital-management-llc/1469623.html.

USPH has been the subject of several recent analyst reports. Zacks Investment Research lowered U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research report on Wednesday, June 21st. Barrington Research upgraded U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $68.00 target price for the company in a research report on Monday, July 3rd. Jefferies Group LLC restated a “hold” rating and set a $63.00 target price on shares of U.S. Physical Therapy in a research report on Friday, June 30th. Cantor Fitzgerald initiated coverage on U.S. Physical Therapy in a research report on Monday, July 24th. They set an “overweight” rating and a $72.00 target price for the company. Finally, BidaskClub lowered U.S. Physical Therapy from a “sell” rating to a “strong sell” rating in a research report on Sunday, July 16th. One research analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $68.50.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.